Celldex Therapeutics - 30 Year Stock Price History | CLDX

Historical daily share price chart and data for Celldex Therapeutics since 1990 adjusted for splits. The latest closing stock price for Celldex Therapeutics as of July 08, 2020 is 12.15.
  • The all-time high Celldex Therapeutics stock closing price was 3014.70 on March 06, 2000.
  • The Celldex Therapeutics 52-week high stock price is 13.91, which is 14.5% above the current share price.
  • The Celldex Therapeutics 52-week low stock price is 1.50, which is 87.7% below the current share price.
  • The average Celldex Therapeutics stock price for the last 52 weeks is 3.03.
Celldex Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2020 3.7112 2.2500 13.4100 1.5500 12.1500 444.84%
2019 3.2988 3.7571 10.3553 2.0500 2.2300 -24.84%
2018 15.8068 43.7781 46.0270 2.9235 2.9670 -93.03%
2017 44.1016 54.1229 59.3703 33.5832 42.5787 -19.77%
2016 73.3586 224.7376 231.9340 43.0285 53.0735 -77.42%
2015 312.9721 276.0120 476.4618 155.6222 235.0825 -14.08%
2014 267.4752 368.9655 473.6132 166.2669 273.6132 -24.62%
2013 266.9407 104.9475 567.1664 104.6477 362.9685 260.80%
2012 75.1824 41.6792 103.8981 41.5292 100.5997 158.08%
2011 49.8028 63.2684 66.8666 31.6342 38.9805 -36.89%
2010 76.6517 70.6147 141.3793 51.2744 61.7691 -11.78%
2009 101.9175 119.7901 172.4138 62.9685 70.0150 -41.04%
2008 155.2623 100.7899 269.5652 67.9160 118.7406 31.95%
2007 161.1736 246.5754 278.9722 73.7926 89.9910 -62.69%
2006 299.2865 338.3662 457.1544 228.5772 241.1759 -28.72%
2005 271.9586 368.9632 390.5610 208.7792 338.3662 -6.47%
2004 420.2081 496.7504 678.5323 282.5718 361.7639 -26.64%
2003 357.5000 210.5790 554.3447 174.5826 493.1508 142.48%
2002 271.4872 707.3294 721.7280 129.5871 203.3797 -71.82%
2001 845.8938 1159.0843 1519.0484 404.9596 721.7280 -41.63%
2000 1471.3889 415.7585 3014.6991 370.7630 1236.4766 178.14%
1999 331.9312 349.1652 561.5440 201.5799 444.5556 41.14%
1998 391.2824 404.9596 809.9192 190.7810 314.9686 -28.28%
1997 333.6141 291.5709 568.7432 230.3770 439.1562 50.62%
1996 484.5131 584.9416 786.5215 286.1714 291.5709 -48.08%
1995 650.5994 449.9551 966.5035 426.5574 561.5440 24.80%
1994 721.9137 1529.8473 1529.8473 381.5619 449.9551 -67.74%
1993 1211.2862 1304.8698 1461.4541 854.9147 1394.8608 5.16%
1992 1461.5179 2226.3778 2519.7485 1056.4946 1326.4676 -33.00%
1991 1256.0470 516.5484 2474.7530 516.5484 1979.8024 274.15%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.274B $0.004B
CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal antibodies, antibody-targeted vaccines and immunomodulators to create novel disease-specific drug candidates.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $147.997B 16.30
Bristol Myers Squibb (BMY) United States $134.766B 11.26
Gilead Sciences (GILD) United States $94.843B 12.29
CSL (CSLLY) Australia $89.938B 0.00
Vertex Pharmaceuticals (VRTX) United States $76.725B 52.75
Regeneron Pharmaceuticals (REGN) United States $70.449B 27.16
Illumina (ILMN) United States $54.371B 55.87
Biogen (BIIB) United States $45.724B 7.83
Seattle Genetics (SGEN) United States $30.385B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $24.107B 0.00
Alexion Pharmaceuticals (ALXN) United States $23.849B 10.25
Incyte (INCY) United States $23.535B 0.00
BioMarin Pharmaceutical (BMRN) United States $23.279B 211.03
Genmab (GMAB) Denmark $23.005B 18.95
Moderna (MRNA) United States $22.860B 0.00
Genmab (GNMSF) Denmark $21.647B 64.27
Alnylam Pharmaceuticals (ALNY) United States $18.506B 0.00
BeiGene (BGNE) Cayman Islands $15.873B 0.00
BioNTech SE (BNTX) Germany $15.286B 0.00
Exact Sciences (EXAS) United States $13.742B 0.00
Sarepta Therapeutics (SRPT) United States $13.270B 0.00
Galapagos (GLPG) Belgium $13.081B 38.48
Bio-Rad Laboratories (BIO.B) United States $12.955B 58.97
ARGENX SE-ADR (ARGX) Netherlands $11.817B 0.00
Horizon Therapeutics Public (HZNP) Ireland $11.210B 27.59
Bio-Techne Corp (TECH) United States $10.473B 69.19
QIAGEN (QGEN) Netherlands $9.923B 28.85
Immunomedics (IMMU) United States $9.594B 0.00
ACADIA Pharmaceuticals (ACAD) United States $8.791B 0.00
Guardant Health (GH) United States $8.241B 0.00
Exelixis (EXEL) United States $7.334B 25.72
Ascendis Pharma (ASND) Denmark $6.971B 0.00
Repligen (RGEN) United States $6.553B 114.94
Adaptive Biotechnologies (ADPT) United States $6.193B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.835B 125.56
Novavax (NVAX) United States $5.697B 0.00
Acceleron Pharma (XLRN) United States $5.505B 0.00
Vir Biotechnology (VIR) United States $5.432B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.369B 0.00
Reata Pharmaceuticals (RETA) United States $5.251B 0.00
Mirati Therapeutics (MRTX) United States $5.193B 0.00
Zai Lab (ZLAB) China $5.048B 0.00
Emergent Biosolutions (EBS) United States $4.950B 32.44
MyoKardia (MYOK) United States $4.448B 0.00
MorphoSys AG (MOR) Germany $4.393B 34.07
Blueprint Medicines (BPMC) United States $4.263B 0.00
China Biologic Products (CBPO) China $4.244B 23.59
Global Blood Therapeutics (GBT) United States $4.165B 0.00
Amicus Therapeutics (FOLD) United States $4.066B 0.00
Momenta Pharmaceuticals (MNTA) United States $4.061B 0.00
Halozyme Therapeutics (HALO) United States $3.872B 0.00
NeoGenomics (NEO) United States $3.804B 277.77
Inovio Pharmaceuticals (INO) United States $3.709B 0.00
Bluebird Bio (BLUE) United States $3.692B 0.00
Arena Pharmaceuticals (ARNA) United States $3.346B 0.00
Alkermes (ALKS) Ireland $3.239B 63.77
Deciphera Pharmaceuticals (DCPH) United States $3.173B 0.00
Fate Therapeutics (FATE) United States $2.930B 0.00
Insmed (INSM) United States $2.869B 0.00
Denali Therapeutics (DNLI) United States $2.863B 0.00
Amarin (AMRN) Ireland $2.610B 0.00
PHARMA MAR SA (PHMMF) Spain $2.470B 0.00
Twist Bioscience (TWST) United States $2.237B 0.00
Viela Bio (VIE) United States $2.207B 0.00
UniQure (QURE) Netherlands $2.075B 0.00
Alector (ALEC) United States $1.920B 0.00
Editas Medicine (EDIT) United States $1.913B 0.00
Eidos Therapeutics (EIDX) United States $1.898B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.896B 0.00
Principia Biopharma (PRNB) United States $1.863B 0.00
Ligand Pharmaceuticals (LGND) United States $1.797B 69.98
Forma Therapeutics Holdings (FMTX) United States $1.741B 0.00
Adverum Biotechnologies (ADVM) United States $1.738B 0.00
Zymeworks (ZYME) Canada $1.698B 0.00
I-Mab (IMAB) China $1.673B 0.00
Intra-Cellular Therapies (ITCI) United States $1.665B 0.00
Epizyme (EPZM) United States $1.642B 0.00
Cytokineticsorporated (CYTK) United States $1.601B 0.00
Mersana Therapeutics (MRSN) United States $1.530B 0.00
Sorrento Therapeutics (SRNE) United States $1.529B 0.00
Mesoblast (MESO) Australia $1.509B 0.00
Sangamo Therapeutics (SGMO) United States $1.495B 0.00
Beam Therapeutics (BEAM) United States $1.494B 0.00
Revance Therapeutics (RVNC) United States $1.488B 0.00
NantKwest (NK) United States $1.477B 0.00
Zealand Pharma (ZEAL) Denmark $1.469B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.451B 0.00
REGENXBIO (RGNX) United States $1.449B 0.00
Akcea Therapeutics (AKCA) United States $1.404B 0.00
Zealand Pharma (ZLDPF) Denmark $1.369B 0.00
NGM Biopharmaceuticals (NGM) United States $1.353B 0.00
Arvinas (ARVN) United States $1.328B 0.00
Intellia Therapeutics (NTLA) United States $1.281B 0.00
Coherus BioSciences (CHRS) United States $1.276B 8.91
Adaptimmune Therapeutics (ADAP) United Kingdom $1.223B 0.00
Arcus Biosciences (RCUS) United States $1.164B 0.00
Athenex (ATNX) United States $1.091B 0.00
Compugen (CGEN) Israel $1.090B 0.00
Alcobra (ARCT) United States $1.018B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.986B 0.00
VBI Vaccines (VBIV) United States $0.911B 0.00
Retrophin (RTRX) United States $0.899B 0.00
Dynavax Technologies (DVAX) United States $0.868B 0.00
Myriad Genetics (MYGN) United States $0.868B 44.77
Heska (HSKA) United States $0.847B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.834B 35.83
Cara Therapeutics (CARA) United States $0.830B 0.00
Pharming Group (PHGUF) Netherlands $0.820B 21.83
Intrexon (PGEN) United States $0.775B 0.00
Morphic Holding (MORF) United States $0.766B 0.00
Kadmon Holdings (KDMN) United States $0.752B 0.00
Cellectis S.A (CLLS) France $0.750B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.735B 0.00
Castle Biosciences (CSTL) United States $0.723B 0.00
Frequency Therapeutics (FREQ) United States $0.712B 0.00
Codexis (CDXS) United States $0.708B 0.00
Vericel (VCEL) United States $0.686B 126.75
ZIOPHARM Oncology Inc (ZIOP) United States $0.685B 0.00
Cue Biopharma (CUE) United States $0.670B 0.00
Agenus (AGEN) United States $0.658B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Vanda Pharmaceuticals (VNDA) United States $0.632B 5.41
AnaptysBio (ANAB) United States $0.621B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.599B 0.00
MiMedx (MDXG) United States $0.591B 0.00
Kala Pharmaceuticals (KALA) United States $0.581B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.566B 0.00
Athersys (ATHX) United States $0.550B 0.00
Syros Pharmaceuticals (SYRS) United States $0.548B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.535B 0.00
Cel-Sci (CVM) United States $0.527B 0.00
Clovis Oncology (CLVS) United States $0.519B 0.00
UROGEN PHARMA (URGN) United States $0.513B 0.00
NextCure (NXTC) United States $0.512B 0.00
Protagonist Therapeutics (PTGX) United States $0.511B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.506B 0.00
Scholar Rock Holding (SRRK) United States $0.502B 0.00
Anika Therapeutics (ANIK) United States $0.501B 16.12
DBV Technologies S.A (DBVT) France $0.494B 0.00
AC Immune SA (ACIU) Switzerland $0.491B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.467B 0.00
MeiraGTx Holdings (MGTX) United States $0.466B 0.00
Geron (GERN) United States $0.443B 0.00
Merus (MRUS) Netherlands $0.443B 0.00
Prothena (PRTA) Ireland $0.436B 0.00
Precision BioSciences (DTIL) United States $0.430B 0.00
Seres Therapeutics (MCRB) United States $0.428B 0.00
BioDelivery Sciences (BDSI) United States $0.428B 22.47
Aeglea BioTherapeutics (AGLE) United States $0.410B 0.00
Puma Biotechnology (PBYI) United States $0.403B 0.00
MannKind (MNKD) United States $0.388B 0.00
CytomX Therapeutics (CTMX) United States $0.385B 0.00
Albireo Pharma (ALBO) United States $0.382B 0.00
Kamada (KMDA) Israel $0.371B 15.44
Avid Bioservices (CDMO) United States $0.369B 0.00
WAVE Life Sciences (WVE) Singapore $0.357B 0.00
ANI Pharmaceuticals (ANIP) United States $0.352B 6.97
Affimed (AFMD) Germany $0.349B 0.00
OSMOTICA PHARM (OSMT) United States $0.328B 0.00
Prometic Life Sciences (LMNL) Canada $0.328B 0.00
PDL BioPharma (PDLI) United States $0.324B 284.00
Starpharma Holdings (SPHRY) Australia $0.313B 0.00
Cellular Biomedicine (CBMG) United States $0.303B 0.00
ChromaDex (CDXC) United States $0.293B 0.00
Spero Therapeutics (SPRO) United States $0.291B 0.00
Abeona Therapeutics (ABEO) United States $0.286B 0.00
Menlo Therapeutics (MNLO) United States $0.285B 0.00
Pfenex (PFNX) United States $0.282B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.275B 0.00
IBio (IBIO) United States $0.273B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.261B 0.00
Northwest Biotherapeutics (NWBO) United States $0.256B 0.00
IVERIC Bio (ISEE) United States $0.253B 0.00
ADMA Biologics Inc (ADMA) United States $0.250B 0.00
Verastem (VSTM) United States $0.249B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.247B 0.00
Dyadic (DYAI) United States $0.246B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.238B 0.00
Selecta Biosciences (SELB) United States $0.238B 0.00
Five Prime Therapeutics (FPRX) United States $0.236B 0.00
Gritstone Oncology (GRTS) United States $0.234B 0.00
Fortress Biotech (FBIO) United States $0.234B 0.00
HOOKIPA Pharma (HOOK) United States $0.225B 0.00
Pluristem Therapeutics (PSTI) Israel $0.222B 0.00
Aduro Biotech (ADRO) United States $0.218B 0.00
Aptinyx (APTX) United States $0.218B 0.00
XOMA (XOMA) United States $0.214B 0.00
Liquidia Technologies (LQDA) United States $0.214B 0.00
GENFIT S.A (GNFT) France $0.210B 0.00
Strongbridge Biopharma (SBBP) United States $0.208B 0.00
Exicure (XCUR) United States $0.207B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.206B 3.11
Sutro Biopharma (STRO) United States $0.197B 0.00
POXEL SA FRANCE (PXXLF) France $0.190B 0.00
ARAVIVE, INC (ARAV) United States $0.185B 0.00
Bellus Health (BLU) Canada $0.179B 0.00
Trevena (TRVN) United States $0.173B 0.00
Theratechnologies (THTX) Canada $0.170B 0.00
Kindred Biosciences (KIN) United States $0.161B 0.00
CorMedix Inc (CRMD) United States $0.161B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.160B 0.00
Aytu Bioscience (AYTU) United States $0.159B 0.00
Cyclerion Therapeutics (CYCN) United States $0.158B 0.00
VTv Therapeutics (VTVT) United States $0.156B 0.00
Cerecor (CERC) United States $0.155B 0.00
Applied Genetic Technologies (AGTC) United States $0.154B 0.00
Cidara Therapeutics (CDTX) United States $0.153B 0.00
TELA Bio (TELA) United States $0.151B 0.00
Enzo Biochem (ENZ) United States $0.145B 0.00
Celyad SA (CYAD) Belgium $0.143B 0.00
Lumos Pharma (LUMO) United States $0.136B 0.00
VolitionRX (VNRX) United States $0.136B 0.00
Biofrontera AG (BFRA) Germany $0.135B 0.00
PHASEBIO PHARMA (PHAS) United States $0.134B 0.00
Orgenesis (ORGS) United States $0.131B 0.00
Oncobiologics (OTLK) United States $0.131B 0.00
Arbutus Biopharma (ABUS) United States $0.130B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.120B 0.00
Palatin Technologies (PTN) United States $0.119B 3.06
Lineage Cell Therapeutics (LCTX) United States $0.118B 0.00
Celsion (CLSN) United States $0.117B 0.00
Protalix BioTherapeutics (PLX) Israel $0.115B 0.00
AIT Therapeutics (XAIR) United States $0.115B 0.00
AquaBounty Technologies (AQB) United States $0.109B 0.00
Eton Pharmaceuticals (ETON) United States $0.109B 0.00
Checkpoint Therapeutics (CKPT) United States $0.106B 0.00
DiaMedica Therapeutics (DMAC) United States $0.098B 0.00
Cardiff Oncology (CRDF) United States $0.095B 0.00
Windtree Therapeutics (WINT) United States $0.095B 0.00
Cocrystal Pharma (COCP) United States $0.094B 0.00
Unum Therapeutics (UMRX) United States $0.092B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.090B 0.00
Antibe Therapeutics (ATBPF) Canada $0.088B 0.00
Emmaus Life Sciences (EMMA) United States $0.086B 0.00
Organovo Holdings (ONVO) United States $0.084B 0.00
Clearside Biomedical (CLSD) United States $0.084B 0.00
Adocia (ADOCY) France $0.080B 0.00
SESEN BIO, INC (SESN) United States $0.079B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.075B 0.00
Proteostasis Therapeutics (PTI) United States $0.072B 0.00
Catalyst Biosciences (CBIO) United States $0.071B 0.00
AnPac Bio-Medical Science (ANPC) China $0.070B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.069B 0.00
Synlogic (SYBX) United States $0.069B 0.00
Happiness Biotech Group (HAPP) China $0.068B 0.00
Stealth BioTherapeutics (MITO) United States $0.066B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.061B 0.00
Vaccinex (VCNX) United States $0.060B 0.00
Idera Pharmaceuticals (IDRA) United States $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.057B 0.00
Soligenix (SNGX) United States $0.055B 0.00
CollPlant Holdings (CLGN) Israel $0.054B 0.00
Signal Genetics (MGEN) United States $0.054B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.053B 0.00
Vascular Biogenics (VBLT) Israel $0.052B 0.00
Ecology Coatings (ABVC) United States $0.051B 0.00
Pulmatrix (PULM) United States $0.049B 0.00
Curis (CRIS) United States $0.047B 0.00
Edesa Biotech (EDSA) Canada $0.045B 0.00
Apricus Biosciences (SEEL) United States $0.044B 0.00
AmpliPhi Biosciences (ARMP) United States $0.043B 0.00
Prima BioMed (IMMP) Australia $0.042B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Bionano Genomics (BNGO) United States $0.040B 0.00
Advaxis (ADXS) United States $0.035B 0.00
Acorda Therapeutics (ACOR) United States $0.034B 0.00
Cesca Therapeutics (THMO) United States $0.034B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.033B 0.00
Chanticleer Holdings (SONN) United States $0.032B 0.00
OvaScience (MLND) United States $0.032B 0.00
Spherix (AIKI) United States $0.030B 0.00
Aptevo Therapeutics (APVO) United States $0.030B 0.00
Titan Pharmaceuticals (TTNP) United States $0.029B 0.00
Novogen (KZIA) Australia $0.027B 0.00
Alimera Sciences (ALIM) United States $0.027B 0.00
Evogene (EVGN) Israel $0.027B 0.00
BioPharmX (TMBR) United States $0.026B 0.00
Cleveland BioLabs (CBLI) United States $0.026B 0.00
IMMURON (IMRN) Australia $0.026B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.024B 0.00
FORTE BIOSCIENC (FBRX) United States $0.024B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
Prana Biotechnology (ATHE) Australia $0.022B 0.00
Entera Bio (ENTX) Israel $0.021B 0.00
Genetic Technologies (GENE) Australia $0.020B 0.00
MYOS RENS Technology (MYOS) United States $0.016B 0.00
BioCardia (BCDA) United States $0.016B 0.00
Neuralstem (SNCA) United States $0.013B 0.00
VIVUS (VVUS) United States $0.012B 0.00
AEterna Zentaris (AEZS) United States $0.011B 0.00
TRACON Pharmaceuticals (TCON) United States $0.010B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Innate Pharma S.A (IPHA) France $0.000B 0.00